Canada markets close in 22 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
56.80+0.48 (+0.85%)
As of 03:38PM EST. Market open.
Sign in to post a message.
  • R
    Roberta
    What is wrong here--I bought BMY in June for $66.50 and am down $10/share. Nearing my sell point. Was supposed to be headed to $100/share with Celgene buyout. Is it the pending law suits?
  • G
    Garrett
    BMY is now trading near Mar. 2020 pandemic lows. Can't find any news except investment firm UBS which lowered price target to $61.
  • B
    Brett
    What the h ell?
    11 new 52-wk LOWS in S&P 500, incl:
    Disney $DIS
    ViacomCBS $VIAC
    Activision Blizzard $ATVI
    T-Mobile US $TMUS
    Bristol-Myers Squibb $BMY
    Cummins $CMI
    Citrix $CTXS
    PayPal $PYPL
    Western Union $WU
    FleetCor Tech $FLT
    MarketAxess $MKTX
  • A
    Alex
    last low b4 earning was 56.11. lost that support today, means the next support is 45.76
  • E
    Ez$
    $SLS conversation
    $SLS Market Cap 107.068M
    Gps Phase 3 AML data 7 months from now that could be worth $3-5B

    All have partnership or industry comps $JAZZ $XBI $MRKR $ADAP $AXSM
    3 Trial Results coming in DEC and JAN $BMY $RHHBY $MRK
  • R
    Real Immuno Investor 10
    $SLS conversation
    Dec/ Jan to remember $xbi selloff offering a great deal for anyone who knows whats coming here. 3 Massive Trial hits $rhhby $mrk $bmy combination readouts.
  • M
    Mark
    Wow, no one wants this stock. Why not?? They have a decent pipeline and good earnings along with a good dividend. ? What's the deal??
  • G
    Gambling_is_for_casinos
    This is not just BMY. The same 5 stocks get all the gains in the market. Value and dividends are completely ignored.
  • M
    Michael
    Keep reading how this is a solid value play and keep wondering why my shares are continually under water. Seems management has a great knack for buying other companies and does a poor job of bringing their drugs through trials to market. Sad. I have expected much more for a considerable time.
  • R
    Rusty0601
    sorry for the off topic, but can someone explain to me why Omicron is such a big deal. from what I have read, it is less dangerous than the Delta variant, so why the major panic? or is the market just jittery because of the tapering and any excuse will pop this down 2%?
  • M
    Michael
    Very close to a 2 year low. Investors deserve much better than what this management group has delivered.
  • E
    Ez$
    $SLS conversation
    $SLS Market Cap 100.068M
    Gps Phase 3 AML data 7 months from now that will be worth $3-5B
    $jazz bought $cpxx when they published Phase 3 Aml data -- that was 1/4 as good as Gps was in Phase 2
    After holiday weekend rumors, Jazz confirms $1.5B buyout of tiny Celator
    The Wall Street Journal kicked off rumors over the Memorial Day weekend that Ireland’s Jazz Pharmaceuticals was set to buy Celator, and early this morning the two confirmed the $1.5 billion deal was t...
    https://www.fiercebiotech.com/biotech/after-holiday-weekend-rumors-jazz-confirms-1-5b-buyout-tiny-celator

    All the following have partnership or industry comps $JAZZ $XBI
    3 Trial Results coming in DEC and JAN $BMY $RHHBY $MRK
  • A
    Alex
    warren buffet sold/selling for a reason. he's a long term investor believes in fundamentals
  • I
    Irena Boga
    Is BMS being acquired? It is going up!😜
  • G
    Garrett
    Could also be year-end tax selling. Most people have made large gains in 2020 so taking losses in BMY will lower capital gains taxes.
  • R
    Ron Laugesen
    And why is the 1 yr. tgt price at $73.12?
  • S
    Samantha
    I’ve got my order for 1k more in. At some point the market will realize this is a strong company that is way oversold
  • R
    Rusty0601
    this is the reaction to good news, what would happen if they had bad news?
  • d
    dbtunr
    Too many management levels. Too many layers between worker bees and top management. Too much overhead and time wasted in meetings. Too much complexity in systems and ways of doing things. Company needs to be streamlined in all manners.